Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989

RHA Verhoeven, Woutera Louwman, EL Koldewijn, TBJ Demeyere, Jan Willem Coebergh

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)
3 Downloads (Pure)


BACKGROUND: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands. METHODS: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied. RESULTS: The overall incidence rate varied around 1.5 per 1 000 000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour. CONCLUSION: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers. British Journal of Cancer (2010) 103, 1462-1466. doi: 10.1038/sj.bjc.6605914 Published online 28 September 2010 (C) 2010 Cancer Research UK
Original languageUndefined/Unknown
Pages (from-to)1462-1466
Number of pages5
JournalBritish Journal of Cancer
Issue number9
Publication statusPublished - 2010

Cite this